Next Article in Journal
Beyond Exposure Levels: Oxidative Stress as a Unifying Axis Linking Particulate Matter, Light, and Protective Interventions
Previous Article in Journal
BDNF Promotes In Vitro Maturation of Sheep Oocytes by Alleviating Oxidative Stress and Endoplasmic Reticulum Stress
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Peripheral Oxygen Saturation Targets and Hyperoxemia in Critical Care: Influence of pH, FiO2, and Respiratory Failure

1
Institute of Intensive Care Medicine, University Hospital Zurich, University of Zurich, Raemistrasse 100, CH-8091 Zurich, Switzerland
2
Department of Anesthesiology and Intensive Care Medicine, University Hospital Krems–NOE LGA, Karl Landsteiner University, Mitterweg 10, 3500 Krems, Austria
3
Department for Quantitative Biomedicine, University of Zurich, Raemistrasse 100, CH-8091 Zurich, Switzerland
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Antioxidants 2026, 15(2), 235; https://doi.org/10.3390/antiox15020235
Submission received: 2 December 2025 / Revised: 26 January 2026 / Accepted: 9 February 2026 / Published: 11 February 2026
(This article belongs to the Section Health Outcomes of Antioxidants and Oxidative Stress)

Abstract

Oxygen therapy is a cornerstone in the treatment of critically ill patients. However, excess oxygen administration may promote oxidative cellular injury once hemoglobin is fully saturated and additional oxygen remains dissolved, enhancing reactive oxygen species formation. The combined impact of oxygen administration, pH, and respiratory failure on hyperoxemia across saturation ranges is not well understood. We conducted a retrospective study at a tertiary center to assess how these factors modify hyperoxemia frequency in adult ICU patients. Continuous SpO2 measurements were aligned with arterial blood gases (PaO2, pH, FiO2), and hyperoxemia was evaluated using predefined PaO2 thresholds (>120 mmHg and >150 mmHg). Among 21,406 patients with 717,064 paired measurements, prolonged hyperoxemia occurred in over half of mechanically ventilated patients, most commonly in those without or with mild-to-moderate respiratory failure. Acidotic states were associated with higher PaO2 values at comparable SpO2 levels, consistent with a rightward shift in the oxygen–hemoglobin dissociation curve. SpO2 values ≥ 98% were consistently associated with hyperoxemia, whereas 96–97% generally corresponded to PaO2 within physiological ranges. Higher FiO2 markedly increased hyperoxemia probability, allowing derivation of pH-stratified FiO2 exposure limits. Our findings highlight the importance of individualized oxygen therapy, considering pH and respiratory failure phenotype to guide safer oxygen management.

1. Introduction

Oxygen therapy is fundamental in critical care and perioperative medicine to prevent insufficient oxygen levels (hypoxemia) and support organ function. However, supraphysiological arterial oxygen tensions (hyperoxemia) are frequently observed in routine clinical practice. While hypoxemia is carefully avoided, elevated arterial oxygen tension levels (PaO2) are often tolerated, despite accumulating evidence that hyperoxemia represents an undesirable exposure in critically ill patients [1,2,3]. From a physiological perspective, once hemoglobin is fully saturated, additional oxygen is dissolved in plasma without further benefit for oxygen delivery, while experimental and clinical studies have linked excessive oxygen exposure to oxidative pathways and cellular injury [4,5]. Consequently, current guidelines recommend oxygen strategies that avoid both hypoxemia and unnecessary hyperoxemia [6,7,8]. Nevertheless, in daily practice, liberal oxygen administration remains frequent [1].
Peripheral oxygen saturation (SpO2) is widely used for continuous, non-invasive monitoring of oxygenation, but its ability to reflect arterial oxygen tension is limited at high saturation levels. Due to the plateau of the oxygen–hemoglobin dissociation curve, substantial increases in PaO2 may occur with little or no change in SpO2 once saturation exceeds approximately 95–97% [9,10]. This dissociation is further modulated by physiological factors such as temperature, 2,3-diphosphoglycerate, acid-base status, and carbon dioxide tension, all of which influence hemoglobin-oxygen affinity and thereby alter the relationship between SpO2 and PaO2. While temperature effects are generally relevant only at extreme values, the role of 2,3-Diphosphoglycerate, a glycolytic byproduct, is poorly understood and subject to variation due to factors such as diet, physical activity, chronic disease, and hypoxic conditions. Additionally, its routine clinical assessment is limited [11]. Consequently, acid-base status and carbon dioxide tension remain the most practical and routinely monitored modulators in clinical settings [12]. As a result, clinically acceptable SpO2 targets may conceal supraphysiological PaO2 levels, particularly in the presence of acidosis or altered respiratory physiology.
Although the determinants of oxygen transport are well established, real-world data quantifying how frequently hyperoxemia occurs across commonly used SpO2 targets, and how this probability is modified by blood pH, inspired oxygen fraction (FiO2), and severity of respiratory failure, remain limited. Prior studies have largely focused on outcome associations of different oxygenation strategies [13,14,15,16], but have not systematically characterized the physiological exposure to supraphysiological PaO2 across saturation targets in routine clinical practice. It remains unclear how diffusion limitation in advanced respiratory failure influences the likelihood of hyperoxemia at given SpO2 and FiO2 levels.
We therefore performed a large retrospective observational analysis in ICU patients to characterize the relationship between SpO2, PaO2, pH, FiO2, and respiratory failure severity using high-resolution clinical data. Our primary objective was to quantify the probability of exceeding predefined PaO2 thresholds across SpO2 ranges and to assess how acid-base status and respiratory failure modify this relationship. While overall exposure patterns were described for the full cohort, detailed analyses focused on mechanically ventilated patients, in whom hyperoxemia was most prevalent. By providing a physiologically grounded, exposure-based assessment of oxygenation patterns, this study aims to inform more precise interpretation of SpO2 targets in critically ill patients.

2. Materials and Methods

2.1. Study Design and Setting

We conducted a retrospective cohort study at the University Hospital Zurich, a tertiary care center, between November 2017 and December 2022. Ethical approval was granted by the cantonal ethics committee of Zurich (BASEC No. 2019-02015). Patients admitted to the intensive care unit (ICU), including both medical and surgical patients requiring ICU-level saturation monitoring, were screened.

2.2. Study Population

Adults (≥18 years) were eligible if they did not object further use of health data, had continuous SpO2 monitoring and at least one matched arterial blood gas measurement. Patients receiving extracorporeal membrane oxygenation or with implausible physiologic values were excluded. For reference, patients never treated with oxygen were included to assess age-related changes in oxygenation. The final cohort comprised 21,406 patients.

2.3. Data Collection

Clinical data were extracted from the institutional Patient Data Management System, which records vital signs and laboratory results at one-minute intervals. Collected variables included SpO2, PaO2, arterial carbon dioxide tension (PaCO2), arterial pH, FiO2, arterial hemoglobin saturation (SaO2), demographics, comorbidities, and severity of Acute Respiratory Distress Syndrome (ARDS). SpO2 was continuously recorded, whereas arterial blood gas parameters were available at discrete sampling time points.
Arterial blood gas measurements were aligned with the median SpO2 and FiO2 recorded in the preceding five minutes. Details on signal alignment and quality control are provided in the online data supplement.

2.4. Definitions

Hyperoxemia was defined using predefined PaO2 thresholds (>120 mmHg and >150 mmHg), chosen to reflect commonly used supraphysiological ranges in the critical care literature [2,17,18]. Arterial blood gases were stratified by pH (normal 7.35–7.45, acidotic < 7.35, alkalotic > 7.45) and PaCO2 (hypocapnic < 35 mmHg, normocapnic 35–45 mmHg, hypercapnic > 45 mmHg). The PaO2/FiO2 ratio was calculated, and acute respiratory distress syndrome severity was defined according to the Berlin criteria [19]. ARDS severity was used to describe the degree respiratory failure and diffusion impairment, rather than as a marker of overall disease severity or outcome.

2.5. Outcomes

The primary outcome was the frequency and probability of exceeding predefined PaO2 thresholds across SpO2 ranges. Secondary outcomes included the modifying effects of pH, FiO2, age, and severity of acute respiratory distress syndrome.

2.6. Stratification and Subgroup Analyses

In our study, patients were categorized based on their oxygen treatment status, with three primary groups: mechanically ventilated patients (invasive and non-invasive), patients receiving oxygen therapy (nasal cannula, high-flow nasal cannula, face mask), and patients without supplemental oxygen. These groups were not mutually exclusive, as each patient had multiple measurements across different time points, and their treatment modality could change over time. This means that a patient could, at different times, fall into more than one group based on the oxygen therapy or ventilation they received at that specific time. In contrast, for the age-related analysis, we included only patients who were never treated with oxygen.
The numbers of paired measurements and corresponding patients in each group were as follows:
-
mechanically ventilation: 443,225 paired measurements from 17,439 patients
-
oxygen therapy: 208,136 measurements from 15,439 patients
-
no supplemental oxygen: 69,227 measurements from 12,332 patients
-
never treated with oxygen: 4131 measurements from 1140 patients (age-related control group)
Because hyperoxemia was uncommon across the non-mechanically ventilated groups, detailed stratified analyses were restricted to mechanically ventilated patients to ensure sufficient exposure prevalence.

2.7. Statistical Analysis

Clinical characteristics were summarized descriptively. Hyperoxemia prevalence was assessed using patient-level summary statistics during the respective treatment period. Distributions of PaO2 and FiO2 were analyzed using histograms and cumulative distribution functions. In mechanically ventilated patients, where hyperoxemia was sufficiently prevalent to allow stable probability estimates, the joint relationship between oxygen exposure and oxygen saturation was analyzed using FiO2 and SpO2, and contour plots stratified by pH category were used to display absolute probabilities of exceeding predefined PaO2 thresholds. Analyses were performed with MATLAB R2024b.

3. Results

3.1. Patient Characteristics

The cohort included 21,406 adults with 717,064 paired SpO2–arterial blood gas measurements (see Table S1 in the Supplementary Materials). Most patients were aged 60–80 years, and 62% were male. Among the medical and surgical ICU patients included in the study, cardiovascular disease was the most common primary admission diagnosis, followed by malignancy and neurological disorders. Acute respiratory distress syndrome was present in 57% of patients, with 15% classified as mild, 21% as moderate, and 21% as severe (Table 1).
In the subgroup of patients who never received oxygen therapy during their stay (n = 1140), the mean PaO2 was 103 mmHg. In these patients, PaO2 values declined slightly with age, but the reduction was less pronounced than predicted by Sorbini’s formula [20] (see Figure S3 in the Supplementary Materials).

3.2. Prevalence of Hyperoxemia

To distinguish between transient oxygen peaks and sustained exposure, hyperoxemia prevalence was assessed using patient-level summary statistics, specifically the median and maximum PaO2 observed during the treatment period (Figure 1). Median PaO2 values characterize sustained oxygen exposure, whereas maximum PaO2 values capture short-lived peaks, often occurring during procedures or acute clinical events.
When summarized using median PaO2 values, patients without supplemental oxygen and those receiving oxygen showed narrow distributions centered within physiological ranges, with only a small fraction exceeding the predefined hyperoxemia thresholds. In contrast, mechanically ventilated patients exhibited a markedly right-shifted distribution. More than half of mechanically ventilated patients had a median PaO2 above 120 mmHg, indicating sustained exposure to supraphysiological arterial oxygen tensions over a substantial portion of their monitored course (Figure 1A,C). Approximately one third exceeded a median PaO2 above 150 mmHg, reflecting prolonged moderate hyperoxemia at the patient level.
Analysis of maximum PaO2 values revealed a distinct and complementary pattern. While non ventilated patients with oxygen support rarely exceeded moderate hyperoxemia thresholds, mechanically ventilated patients frequently experienced brief but pronounced oxygen peaks (Figure 1B,D). Approximately 80% of mechanically ventilated patients reached maximum PaO2 values above 150 mmHg, with rare extreme values extending beyond 400 mmHg. In contrast, supraphysiological PaO2 values observed in patients without documented oxygen therapy occurred almost exclusively as isolated maxima and likely reflect technical or documentation-related artifacts rather than sustained physiological exposure. These values did not influence patient-level median PaO2 and were not considered further (considered implausible physiologic values).

3.3. FiO2 Exposure Patterns

Inspired oxygen fraction distributions in mechanically ventilated patients demonstrated distinct exposure patterns when summarized at the patient level (Figure 2). Median FiO2 values showed a bimodal distribution with peaks at approximately 35–40% and 80–90%, indicating two commonly employed oxygenation strategies during mechanical ventilation (Figure 2A,C). While the lower peak likely reflects routine maintenance oxygenation, the higher peak suggests sustained use of elevated FiO2 levels in a substantial proportion of patients.
Analysis of maximum FiO2 values revealed an even more pronounced right-skewed distribution (Figure 2B,D). More than half of mechanically ventilated patients were exposed to FiO2 levels above 80% at least once during their ICU stay, and approximately one third reached a maximum FiO2 of 100%. These high FiO2 values most plausibly reflect short-term escalation during acute clinical events, procedures, or preoxygenation, rather than continuous baseline therapy.
The median and maximum FiO2 distributions highlight a clinically relevant separation between prolonged oxygen exposure and transient oxygen peaks, analogous to the patterns observed for PaO2. Importantly, these findings demonstrate that exposure to high inspired oxygen fractions is common in routine ICU practice, providing a physiological context for subsequent analyses examining how FiO2 interacts with SpO2 and blood pH to determine the probability of supraphysiological arterial oxygen tensions.

3.4. Effect of FiO2 Across SpO2 Target Ranges

Across mechanically ventilated patients, the relationship between inspired oxygen fraction and arterial oxygen tension differed markedly by SpO2 target range (Figure 3). When SpO2 was maintained between 96–97%, PaO2 values remained largely within physiological limits across a wide range of FiO2 levels, with only a small proportion exceeding the predefined hyperoxemia thresholds. Even at higher FiO2 levels, PaO2 distributions in this saturation range showed limited rightward extension.
In contrast, SpO2 targets of 98–99% were associated with a pronounced upward shift in PaO2 distributions that became progressively more evident with increasing FiO2. At these saturation levels, PaO2 frequently exceeded the mild hyperoxemia threshold and, at moderate to high FiO2, often surpassed the moderate threshold. This effect was further amplified at SpO2 of 100%, where PaO2 values increased steeply and displayed substantial variability across all but the lowest FiO2 categories.

3.5. Influence of pH on the SpO2-PaO2 Relationship

Acid–base status exerted a strong and systematic influence on the relationship between arterial oxygen saturation and arterial oxygen tension (Figure 3). When PaO2 was plotted against SaO2 (Figure 4A), a clear rightward displacement of the oxygen–hemoglobin dissociation curve was observed under acidotic conditions, whereas alkalosis was associated with lower PaO2 values at comparable saturation levels.
At a fixed SaO2 of 99%, median PaO2 differed markedly across pH groups (Kruskal–Wallis p < 10−300). Acidotic patients (pH < 7.35) exhibited a median PaO2 of 154.5 mmHg (interquartile range [IQR] 132.0–198.8 mmHg; n = 23,159), compared with 126.0 mmHg (IQR 115.5–141.8 mmHg; n = 73,509) in the normophysiological pH group and 117.0 mmHg (IQR 108.0–128.3 mmHg; n = 28,901) under alkalotic conditions. These differences became even more pronounced at SaO2 = 100% (Kruskal–Wallis p < 10−300), where median PaO2 reached 258.0 mmHg (IQR 201.0–317.3 mmHg; n = 8408) in acidotic patients, compared with 220.5 mmHg (IQR 160.5–291.0 mmHg; n = 25,341) in the normophysiological group and 164.3 mmHg (IQR 135.8–245.3 mmHg; n = 8802) in alkalotic patients. Thus, identical arterial oxygen saturations were associated with substantially different, and increasingly supraphysiological, PaO2 values depending on pH, particularly within the saturation plateau.
When PaO2 was referenced to SpO2 (Figure 4B), similar directional trends across pH groups were present, but the separation between groups appeared attenuated and the overall dispersion visually compressed. This apparent smoothing is explained by the behavior of pulse oximetry bias illustrated in Figure 4C. Although the median difference between SpO2 and SaO2 remained close to zero across the saturation range, both the interquartile range and the tail dispersion widened progressively with increasing SaO2, most prominently under acidotic conditions. Consequently, at high saturation levels, SpO2 increasingly masked substantial variability and elevation in PaO2, limiting its ability to reliably reflect arterial oxygen tension.
This effect is summarized in Figure 4D, which shows the difference in PaO2 relative to the normophysiological pH group across the saturation range. The pH-dependent divergence increased sharply within the saturation plateau, highlighting that, small differences in measured saturation corresponded to large and clinically relevant differences in arterial oxygen tension.
Detailed boxplot representations and group-wise distributions at fixed SaO2 and SpO2 levels are provided in the Supplementary Material (Figure S4), supporting the robustness of these findings across the full range of observed data.

3.6. Absolute Probability Estimates

Contour plots were used to visualize the joint relationship between SpO2, FiO2, and the probability of exceeding predefined PaO2 thresholds in mechanically ventilated patients (Figure 5). Across the examined range, probability increased progressively with both higher SpO2 and higher FiO2; however, the increase was non-linear and occurred over relatively narrow SpO2 intervals. In particular, probability contours showed a steep transition beginning at SpO2 values of approximately 97–98%, beyond which small increments in saturation were associated with large increases in the probability of hyperoxemia across a wide range of FiO2 levels.
The contour plots further delineated contiguous regions of low and high probability. At lower SpO2 targets, extended areas remained below a 10% probability threshold even at moderate FiO2 levels, whereas at higher SpO2 targets, probability increased rapidly and exceeded 30–50% across commonly used FiO2 ranges. These patterns were consistent across probability thresholds depicted in 10% increments.
Stratified contour plots demonstrated that these probability surfaces were systematically shifted by blood pH (Figures S1 and S2 in the Supplementary Materials). Compared with normal pH, acidotic conditions were associated with leftward and upward displacement of probability contours, indicating higher probabilities of hyperoxemia at lower SpO2 and FiO2 combinations. In contrast, alkalotic conditions shifted contours toward higher SpO2 and FiO2 values. Based on these contour-derived probability surfaces, Table 2 summarizes FiO2 limits stratified by SpO2 and pH corresponding to an absolute probability of hyperoxemia below 10%.
At high inspired oxygen fractions (FiO2 > 0.8), the probability of hyperoxemia did not continue to increase monotonically but instead plateaued or declined in the overall cohort. To clarify this pattern, PaO2-SpO2 density distributions were examined across strata of ARDS severity (Figure 6).
Patients without ARDS and those with mild ARDS most frequently exceeded the predefined hyperoxemia thresholds, with density distributions extending into supraphysiological PaO2 ranges at high SpO2 values. In contrast, patients with severe ARDS demonstrated markedly compressed PaO2 distributions despite high SpO2 and FiO2 exposure, rarely reaching PaO2 levels associated with hyperoxemia. Patients with moderate ARDS showed intermediate patterns between these extremes.

4. Discussion

This large retrospective analysis of more than 700,000 paired SpO2–arterial blood gas measurements from over 21,000 critically medical and surgical patients provides a detailed characterization of arterial oxygen exposure in routine clinical practice. Rather than evaluating clinical outcomes, our study focuses on the physiological conditions under which supraphysiological arterial oxygen tensions occur and how commonly used saturation targets interact with inspired oxygen fraction, acid-base status, and respiratory failure severity grades. Several findings emerge that extend prior observations and help contextualize current oxygenation practices.
A first key observation is the strong association between high peripheral oxygen saturation targets and the probability of hyperoxemia. Across a wide range of clinical conditions, SpO2 values ≥98% were consistently associated with supraphysiological PaO2 levels, whereas a target range of 96–97% was generally associated with PaO2 values below commonly used hyperoxemia thresholds (Figure 3). Although this saturation range is widely considered “normal” in clinical practice, our data demonstrate that small differences within the upper plateau of the oxygen–hemoglobin dissociation curve translate into substantial differences in arterial oxygen exposure. This finding does not contradict established physiological principles but quantifies their impact under real-world conditions and across a large and heterogeneous ICU population.
Inspired oxygen fraction emerged as a major determinant of arterial oxygen exposure, not only through its absolute level but also through the duration and variability of exposure. The bimodal FiO2 distribution observed in mechanically ventilated patients, with peaks around 35–40% and 80–90%, reflects common management strategies, including routine oxygen supplementation and short-term escalation during procedures or acute deterioration (Figure 2). Importantly, our analysis distinguishes between sustained oxygen exposure and transient FiO2 peaks, showing that hyperoxemia is not limited to brief extremes but frequently reflects prolonged exposure at commonly applied FiO2 levels. These findings emphasize that arterial hyperoxemia can occur even in the absence of exceptionally high FiO2 when saturation targets are set near the upper plateau of hemoglobin saturation.
Blood pH acted as a systematic physiological modifier of arterial oxygen exposure. Acidosis was associated with higher PaO2 values at equivalent SpO2 or SaO2 levels, consistent with rightward shifts in the oxygen–hemoglobin dissociation curve. As a result, hyperoxemia occurred at lower saturation targets under acidotic conditions compared with normal or alkalotic pH. This effect was not confined to extreme values but was evident across commonly encountered clinical ranges (Figure 4). While the influence of pH on hemoglobin-oxygen affinity is well established, our findings demonstrate how this interaction translates into differences in arterial oxygen tension under routine ICU monitoring conditions, where SpO2 is often used as the primary guide for oxygen titration.
The probability-based contour analyses integrate these observations by illustrating how SpO2 and FiO2 jointly determine the likelihood of exceeding predefined PaO2 thresholds (Figure 5). Rather than identifying single cutoffs, these analyses delineate contiguous regions of low and high probability across the SpO2-FiO2 plane. Small increments in SpO2 within the upper saturation range were associated with steep increases in hyperoxemia probability, particularly at moderate to high FiO2 levels. Stratification by pH demonstrated systematic shifts in these probability surfaces, further highlighting that identical saturation targets may correspond to markedly different arterial oxygen exposures depending on physiological context (Figures S1 and S2). The FiO2 ranges summarized in Table 2 are derived directly from these probability surfaces and should be interpreted as exposure-associated ranges rather than prescriptive targets.
An important and potentially counterintuitive finding concerns the relationship between respiratory failure severity and hyperoxemia. Patients without ARDS or with mild ARDS most frequently exceeded hyperoxemia thresholds, whereas patients with severe ARDS rarely achieved supraphysiological PaO2 values despite high FiO2 exposure (Figure 6). This pattern reflects profound diffusion limitation in severe ARDS rather than reduced oxygen delivery intensity. Consequently, hyperoxemia should not be interpreted as a marker of disease severity; instead, it appears most likely in patients with relatively preserved gas exchange who are exposed to liberal oxygenation strategies. This observation helps explain why hyperoxemia risk plateaued or declined at very high FiO2 levels in the overall cohort and underscores the importance of considering respiratory severity when interpreting arterial oxygen exposure (Figure 5).
Age had only a minor influence on arterial oxygen tension in patients without supplemental oxygen, with PaO2 declining less than predicted by classical reference equations [20] (Figure S3 in the Supplementary Materials). Although aging is associated with impaired alveolar diffusion [21,22,23], PaO2 values across age groups in the present analysis remained well below the predefined hyperoxemia thresholds, supporting the appropriateness of using fixed PaO2 cutoffs. These findings suggest that age-specific adjustments are unlikely to meaningfully improve the identification of hyperoxemia or the interpretation of arterial oxygen exposure in routine ICU practice.
Our findings should be viewed in the context of prior randomized controlled trials evaluating different oxygenation strategies [3,13,14,15,16]. Most of these trials compared fixed saturation or PaO2 targets and assessed clinical outcomes, with mixed or inconclusive results. In contrast, our study does not evaluate treatment strategies or outcomes but characterizes physiological oxygen exposure under routine care. By focusing on hyperoxemia as an exposure rather than on oxygen targets as interventions, our analysis provides complementary information that may help interpret why outcome differences have been difficult to demonstrate in heterogeneous patient populations.
It is important to emphasize that elevated oxygen saturation does not inherently imply oxidative injury. Oxidative stress is thought to arise when increases in dissolved arterial oxygen exceed physiological buffering capacity, rather than from hemoglobin-bound oxygen itself [5,24,25,26,27]. The absence of outcome differences in trials comparing PaO2 within physiological ranges reinforces the rationale for making this distinction [14,28]. Our study did not measure biomarkers of oxidative stress or tissue injury; therefore, mechanistic implications remain inferential and are based on established physiological and experimental evidence [17]. The present findings should thus be interpreted as identifying conditions associated with increased arterial oxygen exposure rather than demonstrating downstream biological effects.
Several limitations merit consideration. The retrospective design precludes causal inference, and oxygen delivery practices may reflect institution-specific routines. Arterial blood gases were obtained intermittently, and although careful temporal alignment was performed, short-lived fluctuations in oxygenation may not be fully captured. Our analysis addresses systemic arterial oxygen exposure and does not capture local intra-alveolar oxygen toxicity in severe ARDS [29]. The selection of thresholds was guided by the existing literature. Currently, no standardized cutoff values have been established for degrees of hyperoxemia, and there is considerable variability across studies [30]. For this reason and based on physiological rationale and previous publications [2,17,18] hyperoxemia was arbitrarily defined as mild and moderate when PaO2 exceeded 120 mmHg and 150 mmHg, respectively. Additionally, the study population was predominantly Caucasian, which limits the generalizability of our findings regarding SpO2 accuracy in individuals with darker skin pigmentation [31]. Although oxidative stress is mechanistically linked to hyperoxemia [25,32,33,34,35], our results, derived from an observational dataset, should be interpreted as reflecting physiological plausibility rather than direct causality. Finally, although both medical and surgical patients were included, detailed analyses focused on mechanically ventilated patients, in whom hyperoxemia was most prevalent.

5. Conclusions

Hyperoxemia is common in critically ill patients and is promoted by higher SpO2 targets, elevated FiO2, acid-base disturbances, and respiratory failure severity. SpO2 values above 97% substantially increase the probability of supraphysiological PaO2, whereas a target range of 96–97% is generally associated with lower arterial oxygen exposure across most conditions. Patients with preserved or moderately impaired gas exchange are most susceptible to hyperoxemia, while severe ARDS limits the attainment of supraphysiological PaO2 despite high FiO2 exposure. Together, these findings provide a physiology-based framework for interpreting oxygen exposure in daily practice and highlight the importance of considering FiO2, pH, and respiratory severity degree when titrating oxygen therapy.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/antiox15020235/s1, Table S1: Flowchart of patient selection; Figure S1: Contour plots of absolute risk for mild and moderate hyperoxemia stratified by pH; Figure S2: Contour plots of absolute risk for mild and moderate hyperoxemia stratified by pH > 7.45; Figure S3: Comparison of observed PaO2 values in patients without supplemental oxygen against Sorbini’s predicted values; Figure S4: Relationship between PaO2, SaO2, and SpO2 across different pH categories.

Author Contributions

Conceptualization, M.D., R.F., M.P.H., M.K., R.A.S., C.G. and J.B.; Methodology, M.D., R.F. and J.B.; Software, R.F. and J.B.; Validation, M.D., R.F., J.B., M.P.H., M.K. and R.A.S.; Formal Analysis, R.F. and J.B.; Investigation, M.D. and J.B.; Resources, R.A.S.; Data Curation, R.F. and J.B.; Writing—Original Draft Preparation, M.D. and J.B.; Writing—Review and Editing, M.D. and J.B.; Visualization, M.D., R.F., M.P.H., M.K., R.A.S., C.G. and J.B.; Supervision, J.B.; Project Administration, J.B.; Funding Acquisition, R.A.S. and M.K. All authors have read and agreed to the published version of the manuscript.

Funding

Our trial was partially funded by non-restricted grants to RAS and the Swiss National Science Foundation (SNF, No 320030 192787 to MK). The SNF did not contribute to any steps of study design, data collection, analysis, interpretation, writing or submission of the study. All authors declare no conflicts of interest.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki, and approved by the cantonal ethics committee of Zurich (protocol code 2019-02015 and approve on 3 December 2019).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data presented in this study are available, on reasonable request from the corresponding author, due to Swiss data protection laws.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
PaO2arterial partial pressure of oxygen
SpO2peripheral oxygen saturation
PaO2/FiO2 ratioarterial oxygen tension to inspired oxygen fraction ratio
FiO2inspired oxygen fraction
ICUintensive care unit
PaCO2arterial partial pressure of carbon dioxide
SaO2arterial oxygen saturation
ARDSacute respiratory distress syndrome
RCTrandomized controlled trials

References

  1. Cornet, A.D.; Kooter, A.J.; Peters, M.J.L.; Smulders, Y.M. The potential harm of oxygen therapy in medical emergencies. Crit. Care 2013, 17, 313. [Google Scholar] [CrossRef]
  2. de Jonge, E.; Peelen, L.; Keijzers, P.J.; Joore, H.; de Lange, D.; van der Voort, P.H.J.; Bosman, R.J.; de Waal, R.A.L.; Wesselink, R.; de Keizer, N.F. Association between administered oxygen, arterial partial oxygen pressure and mortality in mechanically ventilated intensive care unit patients. Crit. Care 2008, 12, R156. [Google Scholar] [CrossRef]
  3. Girardis, M.; Busani, S.; Damiani, E.; Donati, A.; Rinaldi, L.; Marudi, A.; Morelli, A.; Antonelli, M.; Singer, M. Effect of Conservative vs Conventional Oxygen Therapy on Mortality Among Patients in an Intensive Care Unit: The Oxygen-ICU Randomized Clinical Trial. JAMA 2016, 316, 1583–1589. [Google Scholar] [CrossRef]
  4. Patel, S.; Jose, A.; Mohiuddin, S.S. Physiology, Oxygen Transport And Carbon Dioxide Dissociation Curve. In StatPearls [Internet]; StatPearls Publishing: Treasure Island, FL, USA, 2025. [Google Scholar]
  5. Turrens, J.F. Superoxide production by the mitochondrial respiratory chain. Biosci. Rep. 1997, 17, 3–8. [Google Scholar] [CrossRef]
  6. O’Driscoll, B.R.; Howard, L.S.; Earis, J.; Mak, V. British Thoracic Society Guideline for oxygen use in adults in healthcare and emergency settings. BMJ Open Respir. Res. 2017, 4, e000170. [Google Scholar] [CrossRef]
  7. Beasley, R.; Chien, J.; Douglas, J.; Eastlake, L.; Farah, C.; King, G.; Moore, R.; Pilcher, J.; Richards, M.; Smith, S.; et al. Thoracic Society of Australia and New Zealand oxygen guidelines for acute oxygen use in adults: ‘Swimming between the flags’. Respirology 2015, 20, 1182–1191. [Google Scholar] [CrossRef]
  8. Helms, J.; Catoire, P.; Abensur Vuillaume, L.; Bannelier, H.; Douillet, D.; Dupuis, C.; Federici, L.; Jezequel, M.; Jozwiak, M.; Kuteifan, K.; et al. Oxygen therapy in acute hypoxemic respiratory failure: Guidelines from the SRLF-SFMU consensus conference. Ann. Intensive Care 2024, 14, 140. [Google Scholar] [CrossRef]
  9. Röttgering, J.G.; de Man, A.M.E.; Schuurs, T.C.; Wils, E.J.; Daniels, J.M.; van den Aardweg, J.G.; Girbes, A.R.J.; Smulders, Y.M. Determining a target SpO2 to maintain PaO2 within a physiological range. PLoS ONE 2021, 16, e0250740. [Google Scholar] [CrossRef]
  10. Crooks, C.J.; West, J.; Morling, J.R.; Simmonds, M.; Juurlink, I.; Briggs, S.; Cruickshank, S.; Hammond-Pears, S.; Shaw, D.; Card, T.R.; et al. Modelling the distribution of the oxygen-haemoglobin dissociation curve in vivo: An observational study. Respir. Physiol. Neurobiol. 2025, 333, 104400. [Google Scholar] [CrossRef]
  11. Jaafar, L.S.; Kourie, C.M.R.; El-Mallah, C.A.; Obeid, O. 2,3-Diphosphoglycerate: The forgotten metabolic regulator of oxygen affinity. Br. J. Nutr. 2025, 134, 803–815. [Google Scholar] [CrossRef]
  12. Durlinger, E.M.J.; Spoelstra-de Man, A.M.E.; Smit, B.; de Grooth, H.J.; Girbes, A.R.J.; Oudemans-van Straaten, H.M.; Smulders, Y.M. Hyperoxia: At what level of SpO2 is a patient safe? A study in mechanically ventilated ICU patients. J. Crit. Care 2017, 39, 199–204. [Google Scholar] [CrossRef]
  13. Semler, M.W.; Casey, J.D.; Lloyd, B.D.; Hastings, P.G.; Hays, M.A.; Stollings, J.L.; Buell, K.G.; Brems, J.H.; Qian, E.T.; Seitz, K.P.; et al. Oxygen-Saturation Targets for Critically Ill Adults Receiving Mechanical Ventilation. N. Engl. J. Med. 2022, 387, 1759–1769. [Google Scholar] [CrossRef]
  14. Schjørring, O.L.; Klitgaard, T.L.; Perner, A.; Wetterslev, J.; Lange, T.; Siegemund, M.; Bäcklund, M.; Keus, F.; Laake, J.H.; Morgan, M.; et al. Lower or Higher Oxygenation Targets for Acute Hypoxemic Respiratory Failure. N. Engl. J. Med. 2021, 384, 1301–1311. [Google Scholar] [CrossRef]
  15. Barrot, L.; Asfar, P.; Mauny, F.; Winiszewski, H.; Montini, F.; Badie, J.; Quenot, J.P.; Pili-Floury, S.; Bouhemad, B.; Louis, G.; et al. Liberal or Conservative Oxygen Therapy for Acute Respiratory Distress Syndrome. N. Engl. J. Med. 2020, 382, 999–1008. [Google Scholar] [CrossRef]
  16. Martin, D.S.; Gould, D.W.; Shahid, T.; Doidge, J.C.; Cowden, A.; Sadique, Z.; Camsooksai, J.; Charles, W.N.; Davey, M.; Francis-Johnson, A.; et al. Conservative Oxygen Therapy in Mechanically Ventilated Critically Ill Adult Patients: The UK-ROX Randomized Clinical Trial. JAMA 2025, 334, 398–408. [Google Scholar] [CrossRef]
  17. Kallet, R.H.; Branson, R.D. Should Oxygen Therapy Be Tightly Regulated to Minimize Hyperoxia in Critically Ill Patients? Respir. Care 2016, 61, 801–817. [Google Scholar] [CrossRef]
  18. Damiani, E.; Donati, A.; Girardis, M. Oxygen in the critically ill: Friend or foe? Curr. Opin. Anaesthesiol. 2018, 31, 129–135. [Google Scholar] [CrossRef]
  19. Force, A.D.T.; Ranieri, V.M.; Rubenfeld, G.D.; Thompson, B.T.; Ferguson, N.D.; Caldwell, E.; Fan, E.; Camporota, L.; Slutsky, A.S. Acute respiratory distress syndrome: The Berlin Definition. JAMA 2012, 307, 2526–2533. [Google Scholar] [CrossRef]
  20. Sorbini, C.A.; Grassi, V.; Solinas, E.; Muiesan, G. Arterial oxygen tension in relation to age in healthy subjects. Respir. Int. Rev. Thorac. Dis. 1968, 25, 3–13. [Google Scholar] [CrossRef]
  21. Cerveri, I.; Zoia, M.C.; Fanfulla, F.; Spagnolatti, L.; Berrayah, L.; Grassi, M.; Tinelli, C. Reference values of arterial oxygen tension in the middle-aged and elderly. Am. J. Respir. Crit. Care Med. 1995, 152, 934–941. [Google Scholar] [CrossRef]
  22. Hardie, J.A.; Vollmer, W.M.; Buist, A.S.; Ellingsen, I.; Mørkve, O. Reference values for arterial blood gases in the elderly. Chest 2004, 125, 2053–2060. [Google Scholar] [CrossRef]
  23. Cardús, J.; Burgos, F.; Diaz, O.; Roca, J.; Barberà, J.A.; Marrades, R.M.; Rodriguez-Roisin, R.; Wagner, P.D. Increase in pulmonary ventilation-perfusion inequality with age in healthy individuals. Am. J. Respir. Crit. Care Med. 1997, 156, 648–653. [Google Scholar] [CrossRef]
  24. Turrens, J.F.; Freeman, B.A.; Levitt, J.G.; Crapo, J.D. The effect of hyperoxia on superoxide production by lung submitochondrial particles. Arch. Biochem. Biophys. 1982, 217, 401–410. [Google Scholar] [CrossRef]
  25. Terraneo, L.; Samaja, M. Comparative Response of Brain to Chronic Hypoxia and Hyperoxia. Int. J. Mol. Sci. 2017, 18, 1914. [Google Scholar] [CrossRef]
  26. Zou, D.; Li, J.; Fan, Q.; Zheng, X.; Deng, J.; Wang, S. Reactive oxygen and nitrogen species induce cell apoptosis via a mitochondria-dependent pathway in hyperoxia lung injury. J. Cell Biochem. 2019, 120, 4837–4850. [Google Scholar] [CrossRef]
  27. Ottolenghi, S.; Sabbatini, G.; Brizzolari, A.; Samaja, M.; Chiumello, D. Hyperoxia and oxidative stress in anesthesia and critical care medicine. Minerva Anestesiol. 2020, 86, 64–75. [Google Scholar] [CrossRef]
  28. Nielsen, F.M.; Klitgaard, T.L.; Siegemund, M.; Laake, J.H.; Thormar, K.M.; Cole, J.M.; Aagaard, S.R.; Bunzel, A.G.; Vestergaard, S.R.; Langhoff, P.K.; et al. Lower vs Higher Oxygenation Target and Days Alive Without Life Support in COVID-19: The HOT-COVID Randomized Clinical Trial. JAMA 2024, 331, 1185–1194. [Google Scholar] [CrossRef]
  29. Bezerra, F.S.; Lanzetti, M.; Nesi, R.T.; Nagato, A.C.; Silva, C.P.E.; Kennedy-Feitosa, E.; Melo, A.C.; Cattani-Cavalieri, I.; Porto, L.C.; Valenca, S.S. Oxidative Stress and Inflammation in Acute and Chronic Lung Injuries. Antioxidants 2023, 12, 548. [Google Scholar] [CrossRef]
  30. Damiani, E.; Adrario, E.; Girardis, M.; Romano, R.; Pelaia, P.; Singer, M.; Donati, A. Arterial hyperoxia and mortality in critically ill patients: A systematic review and meta-analysis. Crit. Care 2014, 18, 711. [Google Scholar] [CrossRef]
  31. Jubran, A.; Tobin, M.J. Reliability of pulse oximetry in titrating supplemental oxygen therapy in ventilator-dependent patients. Chest 1990, 97, 1420–1425. [Google Scholar] [CrossRef]
  32. Bedard, K.; Krause, K.-H. The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology. Physiol. Rev. 2007, 87, 245–313. [Google Scholar] [CrossRef] [PubMed]
  33. Mittal, M.; Siddiqui, M.R.; Tran, K.; Reddy, S.P.; Malik, A.B. Reactive oxygen species in inflammation and tissue injury. Antioxid. Redox Signal. 2014, 20, 1126–1167. [Google Scholar] [CrossRef] [PubMed]
  34. Smith, K.A.; Waypa, G.B.; Schumacker, P.T. Redox signaling during hypoxia in mammalian cells. Redox Biol. 2017, 13, 228–234. [Google Scholar] [CrossRef] [PubMed]
  35. Rahal, A.; Kumar, A.; Singh, V.; Yadav, B.; Tiwari, R.; Chakraborty, S.; Dhama, K. Oxidative stress, prooxidants, and antioxidants: The interplay. BioMed Res. Int. 2014, 2014, 761264. [Google Scholar] [CrossRef]
Figure 1. Hyperoxemia prevalence among ICU patients by oxygen delivery modality. Distribution of arterial oxygen tension (PaO2) by oxygen delivery modality. Histograms (top) and cumulative distributions (bottom) are shown for patients without oxygen (orange), patients receiving oxygen (red), and mechanically ventilated patients (blue). Dashed and dotted lines indicate mild (PaO2 > 120 mmHg) and moderate (PaO2 > 150 mmHg) hyperoxemia thresholds. Hyperoxemia was most frequent in mechanically ventilated patients. Different treatment groups: (A) frequency distribution of median PaO2, (B) frequency distribution of maximum PaO2, (C) cumulative frequency distribution of median PaO2, and (D) cumulative frequency distribution of maximum PaO2.
Figure 1. Hyperoxemia prevalence among ICU patients by oxygen delivery modality. Distribution of arterial oxygen tension (PaO2) by oxygen delivery modality. Histograms (top) and cumulative distributions (bottom) are shown for patients without oxygen (orange), patients receiving oxygen (red), and mechanically ventilated patients (blue). Dashed and dotted lines indicate mild (PaO2 > 120 mmHg) and moderate (PaO2 > 150 mmHg) hyperoxemia thresholds. Hyperoxemia was most frequent in mechanically ventilated patients. Different treatment groups: (A) frequency distribution of median PaO2, (B) frequency distribution of maximum PaO2, (C) cumulative frequency distribution of median PaO2, and (D) cumulative frequency distribution of maximum PaO2.
Antioxidants 15 00235 g001
Figure 2. Distribution of inspired oxygen fraction according to management strategy. Inspired oxygen fraction (FiO2) distributions in mechanically ventilated patients. Histograms (top) and cumulative distributions (bottom) of median and maximum FiO2 per patient. Peaks at 35–40% and 80–90% reflect common management strategies. Over half of patients reached FiO2 > 80% at least once, and one-third received FiO2 of 100%. (A) frequency distribution of median FiO2, (B) frequency distribution of maximum FiO2, (C) cumulative frequency distribution of median FiO2, and (D) cumulative frequency distribution of maximum FiO2.
Figure 2. Distribution of inspired oxygen fraction according to management strategy. Inspired oxygen fraction (FiO2) distributions in mechanically ventilated patients. Histograms (top) and cumulative distributions (bottom) of median and maximum FiO2 per patient. Peaks at 35–40% and 80–90% reflect common management strategies. Over half of patients reached FiO2 > 80% at least once, and one-third received FiO2 of 100%. (A) frequency distribution of median FiO2, (B) frequency distribution of maximum FiO2, (C) cumulative frequency distribution of median FiO2, and (D) cumulative frequency distribution of maximum FiO2.
Antioxidants 15 00235 g002
Figure 3. Comparison of FiO2 levels, PaO2 achieved, and resulting SpO2 across different patient groups. Bars represent SpO2 targets of 96–97% (blue), 98–99% (yellow), and 100% (red). Horizontal lines indicate mild (PaO2 > 120 mmHg) and moderate (PaO2 > 150 mmHg) hyperoxemia thresholds. Saturations ≥ 98% were consistently associated with hyperoxemia.
Figure 3. Comparison of FiO2 levels, PaO2 achieved, and resulting SpO2 across different patient groups. Bars represent SpO2 targets of 96–97% (blue), 98–99% (yellow), and 100% (red). Horizontal lines indicate mild (PaO2 > 120 mmHg) and moderate (PaO2 > 150 mmHg) hyperoxemia thresholds. Saturations ≥ 98% were consistently associated with hyperoxemia.
Antioxidants 15 00235 g003
Figure 4. pH-dependent arterial oxygen exposure and pulse oximetry behavior across the oxygen–hemoglobin saturation range. Panels show the relationship between arterial oxygen tension (PaO2, mmHg) and oxygen saturation, stratified by arterial pH (<7.35, 7.35–7.45, >7.45). (A): PaO2 as a function of SaO2 (0.1% bins). (B): PaO2 as a function of SpO2 (1% bins). Solid lines indicate the median, shaded areas the interquartile range (25th–75th percentile). Dashed horizontal lines denote used hyperoxemia thresholds (120 and 150 mmHg). (C): Difference between SpO2 and SaO2 across SaO2, illustrating pH-dependent pulse oximetry bias; in addition to the median and interquartile range, dotted lines indicate the 5th and 95th percentiles to visualize tail dispersion. (D): Difference in PaO2 relative to the normophysiological pH group (7.35–7.45) at fixed SaO2, demonstrating increasing pH-dependent divergence in the saturation plateau.
Figure 4. pH-dependent arterial oxygen exposure and pulse oximetry behavior across the oxygen–hemoglobin saturation range. Panels show the relationship between arterial oxygen tension (PaO2, mmHg) and oxygen saturation, stratified by arterial pH (<7.35, 7.35–7.45, >7.45). (A): PaO2 as a function of SaO2 (0.1% bins). (B): PaO2 as a function of SpO2 (1% bins). Solid lines indicate the median, shaded areas the interquartile range (25th–75th percentile). Dashed horizontal lines denote used hyperoxemia thresholds (120 and 150 mmHg). (C): Difference between SpO2 and SaO2 across SaO2, illustrating pH-dependent pulse oximetry bias; in addition to the median and interquartile range, dotted lines indicate the 5th and 95th percentiles to visualize tail dispersion. (D): Difference in PaO2 relative to the normophysiological pH group (7.35–7.45) at fixed SaO2, demonstrating increasing pH-dependent divergence in the saturation plateau.
Antioxidants 15 00235 g004
Figure 5. Contour plot of absolute probability for mild and moderate hyperoxemia by normal pH. Absolute probability increased progressively with higher FiO2 and SpO2, with contour lines indicating probabilities in 10% increments. At FiO2 >0.8, the risk plateaued or declined, reflecting the contribution of severe ARDS patients who require high FiO2 but seldom reach hyperoxemia due to diffusion limitation. Color changes from darker to lighter shades represent increasing absolute probability of exceeding the thresholds for mild and moderate hyperoxemia.
Figure 5. Contour plot of absolute probability for mild and moderate hyperoxemia by normal pH. Absolute probability increased progressively with higher FiO2 and SpO2, with contour lines indicating probabilities in 10% increments. At FiO2 >0.8, the risk plateaued or declined, reflecting the contribution of severe ARDS patients who require high FiO2 but seldom reach hyperoxemia due to diffusion limitation. Color changes from darker to lighter shades represent increasing absolute probability of exceeding the thresholds for mild and moderate hyperoxemia.
Antioxidants 15 00235 g005
Figure 6. PaO2-SpO2 density distributions by ARDS severity. Kernel density plots show PaO2-SpO2 combinations across ARDS categories. Patients without ARDS or with mild ARDS most frequently exceeded hyperoxemia thresholds, while severe ARDS rarely did so due to diffusion limitation. Horizontal lines indicate mild (PaO2 > 120 mmHg) and moderate (PaO2 > 150 mmHg) hyperoxemia thresholds. Dashed horizontal lines denote used hyperoxemia thresholds (120 and 150 mmHg).
Figure 6. PaO2-SpO2 density distributions by ARDS severity. Kernel density plots show PaO2-SpO2 combinations across ARDS categories. Patients without ARDS or with mild ARDS most frequently exceeded hyperoxemia thresholds, while severe ARDS rarely did so due to diffusion limitation. Horizontal lines indicate mild (PaO2 > 120 mmHg) and moderate (PaO2 > 150 mmHg) hyperoxemia thresholds. Dashed horizontal lines denote used hyperoxemia thresholds (120 and 150 mmHg).
Antioxidants 15 00235 g006
Table 1. Baseline demographic and clinical characteristics of the study cohort (n = 21,406).
Table 1. Baseline demographic and clinical characteristics of the study cohort (n = 21,406).
Demographic Characteristics (n = 21,406)
Baseline characteristics of the included population
Age (mean ± standard deviation) years                62.4 ± 16.5
Age groups (years):                       Number patients (%)
        18–40                      2463 (11.5 %)
        40–60                      5731 (26.8 %)
        60–80                     10,234 (47.8 %)
         >80                      2978 (13.9 %)
Female                              8068 (37.7 %)
Male                               13,338 (62.3 %)
Baseline characteristics of patients without oxygen Therapy
Age group (years)       Mean PaO2 (mmHg)        Number patients
        18–35           106.8         150
        36–50           105.1         175
        51–65           99           235
        66–80           101.6         352
        81–100            105.2          228
Primary admission categories                 Number patients (%)
Cardiovascular diseases                      8153 (37.4)
Malignancies                            3937 (18.1)
Neurological disorders                      1856 (8.5)
Chronic respiratory disease                     1791 (8.2)
Trauma-related conditions                      1770 (8.1)
Gastrointestinal disorders                       1509 (6.9)
Infection                              1384 (6.4)
Endocrine disorders                        331 (1.5)
Others                              1062 (4.9)
Relevant diagnoses and comorbidities                                   
Heart failure                           5339 (24.5)
Acute kidney injury                       5085 (23.3)
Acute or chronic kidney disease                    3619 (16.6)
Delirium                            4299 (19.7)
SIRS (systemic inflammatory response syndrome)           2554 (11.7)
Acute exacerbation of COPD                     1792 (8.2)
Metabolic Acidosis                          1553 (7.1)
Sepsis                                1122 (5.2)
Acute Respiratory distress Syndrome (ARDS)           
              No ARDS                 9290 (42.6)
              Mild                    3344 (15.3)  
              Moderate                    4604 (21.2)
              Severe                   4555 (21.1)
Table 2. FiO2 ranges associated with an absolute probability of hyperoxemia < 10%, stratified by SpO2 and pH. Values are shown separately for mild (PaO2 > 120 mmHg) and moderate (PaO2 > 150 mmHg) hyperoxemia thresholds.
Table 2. FiO2 ranges associated with an absolute probability of hyperoxemia < 10%, stratified by SpO2 and pH. Values are shown separately for mild (PaO2 > 120 mmHg) and moderate (PaO2 > 150 mmHg) hyperoxemia thresholds.
Observed SpO2 (%)pH GroupMaximum Safe FiO2 for Mild HyperoxemiaMaximum Safe FiO2 for Moderate Hyperoxemia
94%Alkalotic100%100%
Normal80%90%
Acidotic75%85%
95%Alkalotic70%85%
Normal65%75%
Acidotic65%70%
96%Alkalotic60%65%
Normal50%60%
Acidotic50%60%
97%Alkalotic40%50%
Normal30–40%50%
Acidotic30%45%
98–100%Alkalotic30%35–40%
Normal30%35–40%
Acidotic30%30–35%
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Delgado, M.; Fritze, R.; P. Hilty, M.; Krauthammer, M.; Schuepbach, R.A.; Ganter, C.; Bartussek, J. Peripheral Oxygen Saturation Targets and Hyperoxemia in Critical Care: Influence of pH, FiO2, and Respiratory Failure. Antioxidants 2026, 15, 235. https://doi.org/10.3390/antiox15020235

AMA Style

Delgado M, Fritze R, P. Hilty M, Krauthammer M, Schuepbach RA, Ganter C, Bartussek J. Peripheral Oxygen Saturation Targets and Hyperoxemia in Critical Care: Influence of pH, FiO2, and Respiratory Failure. Antioxidants. 2026; 15(2):235. https://doi.org/10.3390/antiox15020235

Chicago/Turabian Style

Delgado, Marcos, Robert Fritze, Matthias P. Hilty, Michael Krauthammer, Reto A. Schuepbach, Christoph Ganter, and Jan Bartussek. 2026. "Peripheral Oxygen Saturation Targets and Hyperoxemia in Critical Care: Influence of pH, FiO2, and Respiratory Failure" Antioxidants 15, no. 2: 235. https://doi.org/10.3390/antiox15020235

APA Style

Delgado, M., Fritze, R., P. Hilty, M., Krauthammer, M., Schuepbach, R. A., Ganter, C., & Bartussek, J. (2026). Peripheral Oxygen Saturation Targets and Hyperoxemia in Critical Care: Influence of pH, FiO2, and Respiratory Failure. Antioxidants, 15(2), 235. https://doi.org/10.3390/antiox15020235

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop